Polysaccharide-encapsulated organisms are the leading cause of bacterial meningitis and pneumonia in children. The use of protein–polysaccharide conjugate vaccines in developed …
ME Pichichero - Human vaccines & immunotherapeutics, 2013 - Taylor & Francis
The immunogenicity of polysaccharides as human vaccines was enhanced by coupling to protein carriers. Conjugation transformed the T cell-independent polysaccharide vaccines of …
X Sun, G Stefanetti, F Berti… - Proceedings of the …, 2019 - National Acad Sciences
Glycoconjugate vaccines are among the most effective interventions for preventing several serious infectious diseases. Covalent linkage of the bacterial capsular polysaccharide to a …
Centers for Disease Control and … - MMWR: Morbidity & …, 2011 - search.ebscohost.com
Abstract On October 27, 2010, the Advisory Committee on Immunization Practices (ACIP) approved updated recommendations for the use of quadrivalent (serogroups A, C, Y, and W …
EDG McIntosh, M Bröker, J Wassil, JA Welsch… - Vaccine, 2015 - Elsevier
Complement is an essential component of the immune system and human pathogenic organisms have developed various mechanisms for evading complement mediated serum …
JF Kearney, P Patel, EK Stefanov… - Annual review of …, 2015 - annualreviews.org
In this review we discuss the effects of microbial exposure on the B cell repertoire. Neonatal exposure to conserved bacterial carbohydrates and phospholipids permanently reprograms …
M Vella, D Pace - Expert opinion on biological therapy, 2015 - Taylor & Francis
Introduction: Globally, the three main pathogens causing serious infections are Haemophilus influenzae type b, Streptococcus pneumoniae and Neisseria meningitidis …
MD Snape, DF Kelly, S Lewis, C Banner, L Kibwana… - Bmj, 2008 - bmj.com
Objective To determine the persistence of bactericidal antibody titres following immunisation with serogroup C meningococcal glycoconjugate vaccine at age 6-15 years in order to …
ME Pichichero - Pediatrics, 2009 - publications.aap.org
Almost all current vaccines work by the induction of antibodies in serum or on the mucosa to block adherence of pathogens to epithelial cells or interfere with microbial invasion of the …